Live
- Activist Harassed and Attacked While Documenting Elephant’s Ordeal at Tamil Nadu Temple
- BJP Accuses Congress of Incorrect India Map on Posters, Slams 'Mohabbat ki Dukaan' for Appeasing China
- DIGIDHAN Mission driving India’s leadership role in digital payments: Finance Ministry
- KLH Bachupally Campus Students Showcase Outstanding Athletic Talent and Achievements
- ITC HOTELS’ OPEN WELCOM HOTEL JABALPUR IN MADHYA PRADESH
- Hyundai IONIQ 5 takes part in GUINNESS WORLD RECORDS™ title for the Greatest altitude change by an electric car
- Xiaomi Pad 7 India Launch on January 10: Expected Price, Specifications, Features, and More
- Muzigal launches its State-of-the-art Music Academy in Miyapur, Hyderabad.
- AP Weather Alert: Meteorological Department Issues Rain Warning for Next 2 Days
- Toyota Kirloskar Motor Unveils “Happier Paths Together” – A Corporate Campaign Championing Happiness for All
Covaxin booster enhances vaccine effectiveness against Delta, Omicron variants: ICMR study
Covaxin booster enhances vaccine effectiveness against Delta, Omicron variants
The Indian Council of Medical Research (ICMR) has found in a study that a Covaxin booster dose enhances the vaccine effectiveness against the Delta variant infection and gives protection against the Omicron variants BA.1.1 and BA.2.
New Delhi, June 15: The Indian Council of Medical Research (ICMR) has found in a study that a Covaxin booster dose enhances the vaccine effectiveness against the Delta variant infection and gives protection against the Omicron variants BA.1.1 and BA.2.
The protective efficacy of Covaxin following the second and third dose immunisations were compared against the Delta variant and also studied the efficacy of Covaxin against Omicron variants in a Syrian hamster model in the study. The ICMR scientists also studied the antibody response, clinical observations, viral load reduction and lung disease severity after virus challenge.
"Protective response in terms of the reduction in lung viral load and lung lesions were observed in both the 2 doses as well as 3 doses Covaxin immunised group when compared to placebo group following the Delta variant challenge," the ICMR study said.
The study said that in spite of the comparable neutralising antibody response against the homologous vaccine strain in both second dose and third dose immunised groups, considerable reduction in the lung disease severity was observed in the third dose immunised group post Delta variant challenge indicating the involvement of cell mediated immune response also in protection.
"In the vaccine efficacy study against the Omicron variants i.e., BA.1 and BA.2, lesser virus shedding, lung viral load and lung disease severity were observed in the immunised groups in comparison to the placebo groups," the study underlined.
It said that the present study shows that administering of Covaxin booster dose will enhance the vaccine effectiveness against the Delta variant infection and give protection against the Omicron variants BA.1.1 and BA.2.
However, the findings of the study are a preprint and have not been certified by peer review.
